Novus Therapeutics Inc (NVUS)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current NVUS market cap is 353.29M. The company's latest EPS is USD -1.6665 and P/E is -2.40.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -11.2M | -10.34M | -10.87M | -14.5M | -20.51M |
| Net Income | -10.35M | -9.63M | -10.3M | -58.24M | 76.97M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -16.05M | -18.47M | -36.87M | -88.43M | -43M |
| Net Income | -16.01M | -22.81M | -34.51M | -87.97M | -40.33M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 96.07M | 89.07M | 80.82M | 120.48M | 114.58M |
| Total Liabilities | 4.73M | 5.65M | 6M | 128.98M | 38.52M |
| Total Equity | 91.34M | 83.42M | 74.82M | -8.5M | 76.06M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 10.93M | 197.19M | 170.55M | 92.79M | 89.07M |
| Total Liabilities | 1.47M | 6.59M | 6.55M | 8.61M | 5.65M |
| Total Equity | 9.47M | 190.6M | 164M | 84.18M | 83.42M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -30.4M | -39.53M | -8.74M | -16.52M | -28.28M |
| Investing | -55.36M | -45.29M | 9.78M | -10.13M | -22.93M |
| Financing | 33.02M | 33.02M | 1,000 | 48.07M | 53.36M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -13.86M | -15.21M | -28.91M | -28.42M | -39.53M |
| Investing | N/A | 11.04M | N/A | N/A | -45.29M |
| Financing | 9.68M | 109.58M | -449k | N/A | 33.02M |
| Market Cap | 353.29M |
| Price to Earnings Ratio | -2.40 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 20.99 |
| Price to Book Ratio | 1.16 |
| Dividend Yield | - |
| Shares Outstanding | 24.2M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 6.35 (30.24%) |
| Company Name | Novus Therapeutics Inc |
| Address |
8 the green dover, delaware 19901 |
| Website | https://www.eledon.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
